Levodopa prodrug mesylate hydrate
US8399513B2 · kind B2 · utility
1Cited by
53References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 19, 2009 |
| Grant date | Mar 19, 2013 |
| Priority date | — |
| Expiry date | Mar 5, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Crystalline (2R)-2-phenylcarbonyloxypropyl (2S)-2-amino-3-(3,4-dihydroxyphenyl)propanoate mesylate, hydrate, methods of making the hydrate, pharmaceutical compositions containing the hydrate, and methods of using the hydrate to treat diseases or disorders such as Parkinson's disease are provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.